EKTAF (Elekta AB) Total Equity: $771 Mil (As of Apr. 2026)


EKTAF Elekta AB EKTAF
79 GF Score
Price $5.04
GF Value $5.78
Valuation Modestly Undervalued
! 6 Warning Signs
View Full Analysis

What is Elekta AB Total Equity?

Elekta AB EKTAF 79 Total Equity is $771 Mil as of Apr. 2026. GuruFocus rates EKTAF with a GF Score™ of 79/100 and a GF Value™ of $5.78 (Modestly Undervalued). The stock has 6 warning signs investors should review.

Elekta AB's total equity for the quarter that ended in Apr. 2026 was $771 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.

Elekta AB Total Equity Historical Data

* Premium members only.

The historical data trend for Elekta AB's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Elekta AB Total Equity Chart

Elekta AB Annual Data
Trend Apr17 Apr18 Apr19 Apr20 Apr21 Apr22 Apr23 Apr24 Apr25 Apr26
Total Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 932.68 940.53 996.69 905.68 771.18

Elekta AB Quarterly Data
Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25 Apr25 Jul25 Oct25 Jan26 Apr26
Total Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 905.68 951.50 900.98 881.44 771.18
EKTAF
79GF Score
Elekta AB EKTAF
Total Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Elekta AB Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

Elekta AB's Total Equity for the fiscal year that ended in Apr. 2026 is calculated as

Total Equity=Total Assets(Q: Apr. 2026 )-Total Liabilities(Q: Apr. 2026 )
=2908.112-2136.931
=771

Elekta AB's Total Equity for the quarter that ended in Apr. 2026 is calculated as

Total Equity=Total Assets(Q: Apr. 2026 )-Total Liabilities(Q: Apr. 2026 )
=2908.112-2136.931
=771

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Equity →
What does a Total Equity of $771 Mil mean?
Elekta AB (EKTAF) has a Total Equity of $771 Mil as of Apr. 2026. The total amount of equity as record on a company's balance sheet. View historical data for Elekta AB and its competitors.
Is Elekta AB's Total Equity too high?
Elekta AB's current Total Equity is $771 Mil. Overall, Elekta AB has a GF Score™ of 79/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Elekta AB's Total Equity compare to ABT and SYK?
Elekta AB's Total Equity of $771 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Equity for a Medical Devices & Instruments company?
A good Total Equity depends on the Medical Devices & Instruments industry context. However, Total Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Equity mean?
A high Total Equity can signal that a stock is expensive relative to its fundamentals. The total amount of equity as record on a company's balance sheet. View historical data for Elekta AB and its competitors. Elekta AB's current Total Equity is $771 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Elekta AB stock overvalued right now?
Based on GuruFocus' analysis, Elekta AB (EKTAF) is currently considered Modestly Undervalued. The stock's GF Value™ is $5.78, compared to a current price of $5.04 — trading 12.8% below its estimated fair value. The current Total Equity is $771 Mil. Elekta AB's overall GF Score™ is 79/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Equity calculated?
Total Equity is calculated from a company's financial statements. For Elekta AB (EKTAF), the current Total Equity is $771 Mil as of Apr. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Elekta AB (EKTAF) Overvalued in 2026?

Based on GuruFocus' analysis, Elekta AB stock appears to be undervalued. The current stock price of $5.04 is trading 12.8% below its estimated GF Value™ of $5.78. GuruFocus considers Elekta AB to be Modestly Undervalued.

Key valuation signals for EKTAF:

  • Total Equity: $771 Mil
  • GF Value™: $5.78 vs. price of $5.04 (12.8% below fair value)
  • GF Score™: 79/100 with 6 warning signs

No single metric tells the full story. See the EKTAF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Elekta AB Business Description

Address Hagaplan 4, Box 7593, Stockholm, SWE, 11368
Sweden-based Elekta develops, manufactures, and distributes treatment planning systems for neurosurgery and radiotherapy, including stereotactic radiosurgery and brachytherapy. The company has an installed base of more than 7,300 linear accelerators, Gamma Knife and Unity platforms, as well as brachytherapy installations. The company's sales are evenly distributed across geographies, with North and South America accounting for 29%; Europe, the Middle East, and Africa accounting for 37%; and the Asia-Pacific contributing the remainder.
79GF Score

Get the complete analysis for EKTAF

Total Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$5.04
Price
$5.78
GF Value